🔴 Novanta is trading 4.23% down today; no clear catalyst identified

Novanta is trading at $150.47 (-4.23%), with no clear catalyst identified.

• No new company-specific announcement explaining the August 19, 2026 decline was identified.
• Recent coverage highlights strong second-quarter results, raised 2026 guidance, and the completed Riverpoint Medical acquisition.
• Novanta is underperforming broader markets, with major indexes higher; the catalyst remains unclear rather than clearly macro-driven.